Our previous studies showed that B7-H3 (also known as CD276) is a tumor-associated antigen expressed on the surface of various cancer cell types and can be effectively targeted by B7-H3 specific CAR T cells [30, 50–53]. The gene discussed is CD276; the disease is neoplasm.